Comparison of the Immunogenicity and Reactogenicity of a Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine in Male and Female Adolescents and Young Adult Women

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

2004 • 1,624 citations

A Controlled Trial of a Human Papillomavirus Type 16 Vaccine

2002 • 1,570 citations

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

2005 • 1,551 citations

Sexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000

2004 • 1,232 citations

Sexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000

2004 • 1,149 citations

Comparative analysis of two rates

1985 • 1,009 citations

The epidemiology of human papillomavirus infections

2005 • 935 citations

Chapter 1: Human Papillomavirus and Cervical Cancer--Burden and Assessment of Causality

2003 • 818 citations

Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study

2001 • 814 citations

Male Circumcision, Penile Human Papillomavirus Infection, and Cervical Cancer in Female Partners

2002 • 813 citations

Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective study

1999 • 700 citations

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine

2004 • 541 citations

Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia

2006 • 452 citations

External Genital Warts: Diagnosis, Treatment, and Prevention

2002 • 355 citations

Human Papillomavirus Vaccine Acceptability Among Parents of 10- to 15-Year-Old Adolescents

2004 • 351 citations

Potential Health and Economic Impact of Adding a Human Papillomavirus Vaccine to Screening Programs

2003 • 347 citations

Cost Effectiveness of a Potential Vaccine forHuman papillomavirus

2003 • 321 citations

Simultaneous Quantitation of Antibodies to Neutralizing Epitopes on Virus-Like Particles for Human Papillomavirus Types 6, 11, 16, and 18 by a Multiplexed Luminex Assay

2003 • 281 citations

Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case–control study nested within the Manchester cohort

2000 • 267 citations

Parental acceptance of the human papillomavirus vaccine

2005 • 247 citations

Optimization and Validation of a Multiplexed Luminex Assay To Quantify Antibodies to Neutralizing Epitopes on Human Papillomaviruses 6, 11, 16, and 18

2005 • 245 citations

The Theoretical Population-Level Impact of a Prophylactic Human Papilloma Virus Vaccine

2002 • 233 citations

Cervical Coinfection with Human Papillomavirus (HPV) Types as a Predictor of Acquisition and Persistence of HPV Infection

2001 • 224 citations

The Health and Economic Burden of Genital Warts in a Set of Private Health Plans in the United States

2003 • 223 citations

A Study of 10 296 Pediatric and Adolescent Papanicolaou Smear Diagnoses in Northern New England

1999 • 136 citations

Human Papillomavirus Type 11 (HPV‐11) Neutralizing Antibodies in the Serum and Genital Mucosal Secretions of African Green Monkeys Immunized with HPV‐11 Virus‐like Particles Expressed in Yeast

1997 • 134 citations

Management of anogenital warts (condylomata acuminata).

2001 • 108 citations

Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis

1997 • 105 citations

A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine

2004 • 94 citations

Twenty years' experience of rubella vaccination in Sweden: 10 years of selective vaccination (of 12-year-old girls and of women postpartum) and 13 years of a general two-dose vaccination

1997 • 68 citations

A two-dose hepatitis B vaccine regimen: proof of priming and memory responses in young adults

1998 • 65 citations

Immunogenicity and Reactogenicity of a Novel Vaccine for Human Papillomavirus 16: A 2-Year Randomized Controlled Clinical Trial

2005 • 60 citations

Race/ethnicity and gender disparities in the utilization of a school-based hepatitis B immunization initiative

2004 • 40 citations

An evaluation of school-level factors used in a successful school-based hepatitis B immunization initiative

2005 • 35 citations

PS10 Late breaking Prophylactic use of quadrivalent human papillomavirus (HPV) (types 6, 11, 16, 18) L1 virus-like particle (VLP) vaccine reduces cervical intraepithelial neoplasia (CIN) 2/3 and adenocarcinoma in situ (AIS) risk

2005 • 28 citations

Race/ethnicity and gender disparities in the utilization of a school-based hepatitis B immunization initiative

2004 • 23 citations

Cited By (0)

No citing papers found in database